Palatin Technologies (PTN) Stock: Climbing On Clinical Data

Palatin Technologies PTN Stock News

Palatin Technologies, Inc. (NYSEAMERICAN: PTN) is having a great day in the market today, and for good reason. The company announced positive clinical data, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The clinical data; what we’re seeing from PTN stock as a result; and what we’ll … Read more

Palatin Technologies (PTN) Stock: Headed For The Top On FDA News

Palatin Technologies, Inc. (NYSEAMERICAN: PTN) is having an incredibly strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced news surrounding an accepted New Drug Application (NDA). Of course, the news led to excitement among investors, sending the stock on a run for the top. Today, … Read more

Palatin Technologies (PTN) Stock: Flying On NDA Submission

Palatin Technologies, Inc. (NYSEAMERICAN: PTN) is having an overwhelmingly strong start to the trading session this morning after announcing that it has submitted a New Drug Application (NDA) with the United States Food and Drug Administration (FDA). Of course, the news led to excitement among investors and the stock is making a run for the top … Read more

Palatin Technologies (PTN) Stock: Gaining On FDA Clearance

Palatin Technologies, Inc. (NYSEAMERICAN: PTN) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company released news with regard to an FDA clearance, leading to excitement among investors and sending the stock toward the top. Today, we’ll talk about the news, what we’re seeing from the stock, … Read more

Palatin Technologies (PTN) Stock: Gaining On License Agreement

Palatin Technologies, Inc. (NYSEAMERICAN: PTN) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has signed a license and collaboration agreement. Of course, this led to excitement among investors, sending the stock toward the top. Today, we’ll talk about the agreement, how the … Read more

Palatin Technologies (PTN) Stock: Gaining On Merck & Co. (MRK) Rumors

Palatin Technologies, Inc. (NYSEMKT: PTN) is having an incredibly strong day in the market today. The gains seem to be associated with reports that can be traced back to Wall Street Whispers, suggesting that Merck & Co. is interested in one of the company’s pipeline drugs. Of course, this led to excitement among investors, sending … Read more

Palatin Technologies (PTN) Stock: Is An Acquisition On The Horizons?

Palatin Technologies, Inc. (NYSEMKT: PTN) Palatin Technologies has had an interesting day in the market thus far. Starting high, going low, and now up nearly a third – it’s been like a rollercoaster. Nonetheless, it looks like more good news is coming out that could send the stock further up. Today, we’ll talk about what … Read more

Palatin Technologies (PTN) Stock: Creating A Soulmate For Viagra

Palatin Technologies, Inc. (NYSEMKT: PTN) The provocative television commercials for Viagra may soon be getting a companion with the late stage success of Palatin Technologies’ bremelanotide, an experimental drug intended to boost the libido of pre-menopausal women that are distressed by a lack of sexual desire. Subsequent to the late breaking news after hours on … Read more

Today In Biotech: Palatin Technologies (PTN), Omeros Corporation (OMER), Biocept (BIOC), MannKind (MNKD), Synergy Pharmaceuticals (SGYP)

Palatin Technologies Climbs As Female Viagra Is Approved Palatin Technologies, Inc. (NYSEMKT: PTN) Palatin Technologies is having a great day in the market after Sprout Pharmaceuticals received FDA approval for Addyi; a female sexual dysfunction medication that’s being referred to as “female Viagra”. While Palatin Technologies is in no way connected to Sprout Pharmaceuticals, . … Read more